日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study

异源性 COVID-19 疫苗接种和 mRNA 疫苗加强免疫可增强肝硬化患者的免疫反应：一项前瞻性观察研究

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines11091455
Sripongpun, Pimsiri; Pinpathomrat, Nawamin; Sophonmanee, Ratchanon; Ongarj, Jomkwan; Seepathomnarong, Purilap; Seeyankem, Bunya; Chamroonkul, Naichaya; Piratvisuth, Teerha; Kaewdech, Apichat
免疫/内分泌
肝硬化
发表日期：2023
文献求助 收藏

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population

健康人群皮内注射 ChAdOx1 nCoV-19 增强免疫的免疫原性和安全性

期刊:NPJ Vaccines
影响因子:6.9
doi:10.1038/s41541-022-00475-z
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingv
免疫
新冠
发表日期：2022
文献求助 收藏

Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases

系统性自身免疫性风湿病患者的中和抗体受损，但针对 SARS-CoV-2 的细胞免疫原性仍得以保留。

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-022-00568-9
Intapiboon, Porntip; Uae-Areewongsa, Parichat; Ongarj, Jomkwan; Sophonmanee, Ratchanon; Seepathomnarong, Purilap; Seeyankem, Bunya; Surasombatpattana, Smonrapat; Pinpathomrat, Nawamin
SARS-CoV-2
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine

首次接种灭活 SARS-CoV-2 疫苗后，皮内注射 BNT162b2 mRNA 疫苗加强剂诱导的 T 细胞反应

期刊:Vaccines
影响因子:
doi:10.3390/vaccines10091494
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, Purilap Seepathomnarong, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
免疫
细胞生物学
新冠
其它细胞
发表日期：2022
文献求助 收藏

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population

健康人群接种两剂灭活 SARS-CoV-2 疫苗后皮内注射 BNT162b2 mRNA 疫苗加强剂的免疫原性和安全性

期刊:Vaccines
影响因子:
doi:10.3390/vaccines9121375
Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
免疫
新冠
发表日期：2021
文献求助 收藏